Norway Antimicrobial Resistance Diagnostics Market Size & Outlook
Norway antimicrobial resistance diagnostics market, 2018-2030 (US$M)
Related Markets
Norway antimicrobial resistance diagnostics market highlights
- The Norway antimicrobial resistance diagnostics market generated a revenue of USD 7.7 million in 2021 and is expected to reach USD 13.3 million by 2030.
- The Norway market is expected to grow at a CAGR of 6.3% from 2022 to 2030.
- In terms of segment, pcr was the largest revenue generating technology in 2021.
- Rapid & Point of Care is the most lucrative technology segment registering the fastest growth during the forecast period.
Antimicrobial resistance diagnostics market data book summary
| Market revenue in 2021 | USD 7.7 million |
| Market revenue in 2030 | USD 13.3 million |
| Growth rate | 6.3% (CAGR from 2021 to 2030) |
| Largest segment | Pcr |
| Fastest growing segment | Rapid & Point of Care |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Microbiology Culture, Immunoassay, PCR, NGS, Mass Spectrometry, Rapid & Point of Care, Other Technology |
| Key market players worldwide | BioMerieux SA, Roche, Abbott Laboratories, Hologic Inc, BD, Danaher Corp, Accelerate Diagnostics Inc |
Other key industry trends
- In terms of revenue, Norway accounted for 0.2% of the global antimicrobial resistance diagnostics market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany antimicrobial resistance diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 162.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antimicrobial Resistance Diagnostics Market Scope
Antimicrobial Resistance Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway antimicrobial resistance diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antimicrobial resistance diagnostics market will help companies and investors design strategic landscapes.
Pcr was the largest segment with a revenue share of 24.68% in 2021. Horizon Databook has segmented the Norway antimicrobial resistance diagnostics market based on microbiology culture, immunoassay, pcr, ngs, mass spectrometry, rapid & point of care, other technology covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Norway antimicrobial resistance diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway antimicrobial resistance diagnostics market databook
-
Our clientele includes a mix of antimicrobial resistance diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway antimicrobial resistance diagnostics market, including forecasts for subscribers. This country databook contains high-level insights into Norway antimicrobial resistance diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway antimicrobial resistance diagnostics market report size, by technology, 2018-2030 (US$M)
Norway Antimicrobial Resistance Diagnostics Market Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
